Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 151.0 | 71 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | SCGF-b | 149.0 | 75 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 111.0 | 71 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | SCGF-b | 101.0 | 67 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 198.0 | 53 | ||||
RA1869 | 3 | SCGF-b | 277.0 | 57 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 131.0 | 75 | ||||
N2759 | 3 | SCGF-b | 151.5 | 52 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 168.0 | 61 | ||||
RA1931 | 3 | SCGF-b | 185.5 | 60 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 112.0 | 76 | ||||
N2586 | 3 | SCGF-b | 129.0 | 51 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 178.0 | 69 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 162.0 | 79 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 104.0 | 54 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 80.0 | 64 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 157.5 | 56 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 164.5 | 64 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 95.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 97.0 | 87 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 168.0 | 68 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 252.5 | 58 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 174.0 | 49 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 177.0 | 52 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 160.5 | 60 |